Directory
>
Lev Verkh
Lev Verkh
Chief Regulatory & Clinical Development Officer | Stemedica Cell Technologies, Inc
San Diego, California, United States
Lev Verkh
Summary
Dr. Lev Verkh is a seasoned expert in clinical development and regulatory affairs with nearly 30 years of experience in the biopharmaceutical and biotechnology sectors. He currently serves as the Chief Regulatory & Clinical Development Officer at Stemedica Cell Technologies, where he has successfully led the regulatory approval processes for multiple products in oncology and other fields. Dr. Verkh's extensive background includes significant roles at major companies such as Pfizer and Baxter, where he contributed to pivotal clinical trials and regulatory submissions. His work spans various therapeutic areas, including cardiology, oncology, and neurology, showcasing his versatility and depth in clinical research. He holds advanced degrees in biophysics and theoretical physics, which complement his medical expertise. With over 40 peer-reviewed publications, Dr. Verkh is recognized as a thought leader in his field, actively participating in the design and execution of complex clinical studies across multiple countries. His ability to navigate intricate regulatory landscapes makes him a valuable asset in the development of innovative medical therapies.
Lev Verkh
Work Experience
Chief Regulatory & Clinical Development Officer at
Stemedica Cell Technologies, Inc
January 2010 - Present
Consultant, Pharmacokinetics & First-In-Man Studies at
Pfizer
January 2004 - January 2010
Consultant at
Baxter International
January 2002 - January 2004
Lev Verkh
Education
State University, Odessa, Ukraine, Bachelor Of Applied Science (B.A.Sc.)
SUNY at Buffalo, School of Medicine, Doctor Of Philosophy (Phd)
State University at Buffalo, NY, Master Of Science (M.S.)
Frequently Asked Questions about Lev Verkh
What is Lev Verkh email address?
Lev Verkh's primary email address is ******@stemedica.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Lev Verkh work for?
Lev Verkh is a Chief Regulatory & Clinical Development Officer at Stemedica Cell Technologies, Inc, a company specializing in Commercial physical research.
Where Lev Verkh graduated from?
Lev Verkh holds a degree in Theoretical And Mathematical Physics, Statistics from State University, Odessa, Ukraine.
How can I directly contact Lev Verkh?
To contact Lev Verkh directly, you can use the email address ******@stemedica.com. Complete contact information is available upon registration with Muraena.
Is Lev Verkh an immigrant?
Yes, Lev Verkh is an immigrant and currently based in United States
Who is Lev Verkh?
Dr. Lev Verkh is a seasoned expert in clinical development and regulatory affairs with nearly 30 years of experience in the biopharmaceutical and biotechnology sectors. He currently serves as the Chief Regulatory & Clinical Development Officer at Stemedica Cell Technologies, where he has successfully led the regulatory approval processes for multiple products in oncology and other fields. Dr. Verkh's extensive background includes significant roles at major companies such as Pfizer and Baxter, where he contributed to pivotal clinical trials and regulatory submissions. His work spans various therapeutic areas, including cardiology, oncology, and neurology, showcasing his versatility and depth in clinical research. He holds advanced degrees in biophysics and theoretical physics, which complement his medical expertise. With over 40 peer-reviewed publications, Dr. Verkh is recognized as a thought leader in his field, actively participating in the design and execution of complex clinical studies across multiple countries. His ability to navigate intricate regulatory landscapes makes him a valuable asset in the development of innovative medical therapies.
Lev`s contact details
******@stemedica.com
*********@pfizer.com
Colleagues
Chief Medical Officer
Legate
Chief Regulatory and Clinical Development Officer
Vice Chairman Of The Board
Vice President, Clinical Development
Chief Technology Officer
Corporate Secretary
Vice President, Investor Relations